Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 461-470 of 568 for sleep

Edit search filters
  1. A Study of Patient Reported Outcomes and Use of Self-Efficacy in the Management of Chronic Fibrotic Interstitial Lung Disease

    Rochester, MN

  2. A Study to Evaluate Screening Biomarkers for Lung Cancer

    Jacksonville, FL

  3. Methods of Measuring Height and the Effects on Adult Predicted Lung Function

    Rochester, MN

  4. A Study to Evaluate DDP3 as a Predictor of Cardiogenic Shock in Patients Presenting with Cardiac Symptoms

    Rochester, MN

  5. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker

    Jacksonville, FL

  6. A Registry for the Scientific Study of Pulmonary Hypertension in the United States

    Jacksonville, FL

  7. A Study to Identify and Characterize Neurophysiological Biomarkers for Progression of Neurodegenerative Disease

    Rochester, MN

  8. Influence of Immunosuppresion on Lung Iron Content in Pneumonia

    Scottsdale/Phoenix, AZ

  9. Identification of risk factors and risk markers in Patients with Cavernous Malformations

    Rochester, MN

  10. Early Identification of Pulmonary Coccidioidomycosis

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer